Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2 results about "MOPS" patented technology

MOPS (3-(N-morpholino)propanesulfonic acid) is a buffer introduced by Good et al. in the 1960s. It is a structural analog to MES. Its chemical structure contains a morpholine ring. HEPES is a similar pH buffering compound that contains a piperazine ring. With a pKₐ of 7.20, MOPS is an excellent buffer for many biological systems at near-neutral pH.

A reagent for determining serum choline and its method of use

PendingCN122306908AMOPSTandem mass spectrometry
This invention discloses a reagent for determining choline in serum and its usage method, relating to the field of in vitro diagnostic reagent technology. It comprises the following components: MOPS, polyether F-68, dimethyl sulfoxide, prolin 300, potassium chloride, lithium acetate, calcium acetate, sodium tetraborate, sodium chloride, and choline. This invention provides an electrode filling solution that can be directly used to measure serum choline content using an electrode method. This method requires no sample preparation, has a short detection time, and provides stable and reliable results, avoiding the instability of choline in serum. It is compatible with appropriate equipment for quantitative detection. It solves the problem of inaccurate results due to the easy decomposition of choline during storage and also provides a low-cost method for detecting choline with results equivalent to tandem mass spectrometry.
Owner:HEBEI INST FOR DRUG & MEDICAL DEVICE CONTROL (HEBEI INST FOR COSMETICS CONTROL)

A biofouling mitigation method of synergistically degrading extracellular polymeric substances by multiple enzymes

PendingCN122325005AMicroorganismPOLYMER SUBSTANCE
This invention discloses a method for alleviating bioclogging through the synergistic degradation of extracellular polymers by multiple enzymes, comprising: selecting freeze-dried *Pseudomonas aeruginosa* and reviving and culturing it to obtain bacterial solution a; expanding the reviving bacterial solution a and mixing it to obtain bacterial solution b; re-inoculating bacterial solution b into a new culture medium until the logarithmic growth phase to obtain bacterial solution c; centrifuging bacterial solution c in the logarithmic growth phase and adding MOPS buffer solution to the precipitate to obtain a bacterial suspension; preparing a compound enzyme agent and adding the prepared compound enzyme agent to the bacterial suspension to react and decompose the extracellular polymers secreted by the microorganisms, thereby solving the clogging problem. This invention can alleviate the formation of bioclogging without affecting the water quality of reinjected water. Compared with single enzymes or combinations of two enzymes, it has advantages such as lower dosage, lower cost, better effect, and faster results.
Owner:XIAN RES INST OF CHINA COAL TECH & ENG GRP CORP